22nd Century Group, Inc. Overview
Pro stress-test →22nd Century Group is pioneering the nicotine harm reduction movement in the tobacco industry enabling smokers to take control of their nicotine consumption. The company created its flagship product, the VLN® cigarette, which contains 95% less nicotine than traditional cigarettes and has been proven to allow consumers to greatly reduce their nicotine consumption. The company operates as both a manufacturer of reduced-nicotine branded products and a contract manufacturer for third-party tobacco brands.
Strategic Profile
Pro stress-test →With dozens of patents allowing it to control nicotine biosynthesis in the tobacco plant, the company has developed proprietary reduced nicotine content (RNC) tobacco plants and cigarettes, which have become the cornerstone of the business. The company recently secured a 5-year agreement with Smoker Friendly that includes manufacturing 11 existing brands and launching 8 new premium brands. The company is positioned to benefit from potential FDA-mandated reduced nicotine standards in the tobacco industry.
Competitive Landscape
Pro stress-test →XXII underperformed the US Tobacco industry which returned 25.5% over the past year. The company competes against major tobacco conglomerates (Altria, Philip Morris, Japan Tobacco) in traditional cigarettes while holding a near-monopoly in FDA-approved reduced nicotine combustible cigarettes. Primary competitive advantage is proprietary technology and regulatory approvals, though scale and distribution remain constraints.
Industry Context
22nd Century Group, Inc. operates in Tobacco Products / Biotechnology - Plant Science (Nicotine Harm Reduction).
Key facts
Founded: 1998 · Headquarters: Mocksville, North Carolina, US · Revenue: $7.84M · Market cap: $6.56M